Update on Pediatric Hearing Loss & Cochlear Implantation Anna - - PDF document

update on pediatric hearing loss cochlear implantation
SMART_READER_LITE
LIVE PREVIEW

Update on Pediatric Hearing Loss & Cochlear Implantation Anna - - PDF document

Update on Pediatric Hearing Loss & Cochlear Implantation Anna K. Meyer, MD, FAAP Assistant Professor Division of Pediatric Otolarynoglogy University of California, San Francisco February 16, 2013 No disclosures 2 1 Objectives


slide-1
SLIDE 1

1

Update on Pediatric Hearing Loss & Cochlear Implantation

Anna K. Meyer, MD, FAAP Assistant Professor Division of Pediatric Otolarynoglogy University of California, San Francisco

February 16, 2013

  • No disclosures

2

slide-2
SLIDE 2

2

3

Objectives

  • Common Etiologies
  • Candidacy Evaluation
  • Expanding Criteria

Causes of Hearing Loss

  • Hereditary 40 to 50%
  • Acquired 15-40%
  • Unknown 15-44%

4 Riga, et al., 2005; Gulandi, 2003

slide-3
SLIDE 3

3

Connexin 26 and 30

  • Historical

– Severe to profound – autosomal recessive – bilateral

  • Current

– Range of hearing loss – Unilateral, asymmetric – Progressive – Sudden SNHL – Autosomal dominant: syndromic and non-syndromic

  • palmoplantar keratoderma, Vohwinkel syndrome and

keratitis-ichthyosis/hystrix-like ichthyosis-deafness

5

Connexin 26 Genotype-Phenotype

6

slide-4
SLIDE 4

4

CMV: the ongoing mystery!

  • Estimated 1% of all neonates infected.

– Most no apparent signs of infection at birth. – ~5% with asymptomatic congenital CMV infection present hearing loss before 3 months of age. – mostly sensorineural, profound

  • can be progressive, fluctuating, asymmetric/unilateral

and delayed in onset

  • Diagnosis

– < 3 weeks: CMV viral culture on urine – After 3 weeks: dried blood spot

Deleenheer, 2011 8

Enlarged Vestibular Aqueduct

  • Most common imaging finding
  • High risk for progression
  • Variable hearing at birth from normal to profound
slide-5
SLIDE 5

5

UNHS

  • 1-3/1000 births with hearing loss

– More common than all other diseases screened in neonates combined.

  • Screen by 1 month

– >95%

  • Identify HL by 3 months

– 55%

  • Intervention by 6 months

– 33-53%

  • Birth to kindergarten:????
  • By school age incidence 6/1000

9

White, 2003

10

slide-6
SLIDE 6

6

Hearing Loss Evaluation

  • Prenatal exposures

– TORCH – Ototoxins – Diabetes

  • Perinatal risks

– Hypoxemia

  • NICU admission,

ventilation, low Apgars – Hyperbilirubinemia – Sepsis – Ototoxins – Low birthweight/preemie – Syndromes

  • Post-natal

– Meningitis – Trauma – Progressive loss

  • FH
  • PE

– Undiagnosed syndromes

11

Hearing Loss Evaluation

  • Postnatal

– Infectious

  • Bacterial meningitis

– S. pneumo & N. meningitidis >> H. flu

  • Viral: mumps, measles
  • Check vaccination record

– Delayed motor milestones – Syncope, arrhythmias

  • FH, SH, Medications

12

slide-7
SLIDE 7

7

Audiologic Confirmation

  • Screen: automated ABR: max two!
  • Diagnosis:

– natural sleep ABR – sedated ABR – OAEs – Behavioral testing

13

Etiology Work-up

  • All HL

– Ophthalmologic evaluation

  • Severe to Profound SNHL: EKG
  • Bilateral Loss

– HAs – Genetics – Imaging – Other

  • Unilateral Loss

– HAs – Imaging – Genetics, other

14

slide-8
SLIDE 8

8

15

Effects of Unilateral Hearing Loss

Math Language Math Language Social Math Language Math Language Social 0th 10th 20th 30th 40th 50th 60th Percentile Rank Normal Hearing Unilateral Hearing Loss

Keller & Bundy (1980) (n = 26; age = 12 yrs) Peterson (1981) (n = 48; age = 7.5 yrs) Bess & Thorpe (1984) (n = 50; age = 10 yrs) Blair, Peterson & Viehweg (1985) (n = 16; age = 7.5 yrs) Culbertson & Gilbert (1986) (n = 50; age = 10 yrs)

Average Results Math = 30th percentile Language = 25th percentile Social = 32nd percentile

16

slide-9
SLIDE 9

9

17

Should we limit CT scans?

  • CT in U.S.

– Up to 7 million children annually in 2009 – Head is common region for pediatric CT – Younger patients receive higher radiation dose/unit – Children are more sensitive to radiation

  • 10 fold neoplastic potential

– More years at risk for cancer occurrence – 2001 and 2003 studies show small but significant increase in lifetime risk of fatal cancer

  • 1/1000 children with a single CT scan
  • 0.35% increase > baseline

Brenner,et al., 2001; Slovis, 2003; Linet, et al., 2009

18

Berrington de Gonzalez, A. et al. Arch Intern Med 2009;169:2071-2077.

Projected Number of Future Cancers That Could Be Related to CT Scans Performed in the United States in 2007, According to CT Scan Type

slide-10
SLIDE 10

10

19

CT-limiting Algorithm?

Preciado, et al., 2005 *consider MRI

Candidacy

  • FDA pediatric guidelines

– 12 months or older – Unaided PTA > 90 dB HL – HA trial: 3-6 months – Lack of auditory skills development – Tolerance of HAs

20

slide-11
SLIDE 11

11

Pediatric CI Criteria?

  • Severe SNHL
  • Asymmetric Hearing Loss
  • Unilateral HL
  • Progressive HL
  • Auditory Neuropathy with good pure tones
  • Apparently absent cochlear nerves on MRI
  • 6 month old with confirmed profound SNHL
  • Severely developmentally delayed children
  • Adolescent with long-term severe hearing loss

21

Expanding Criteria

  • <12 months

– Improved phonological skills – Superior speech understanding – Language skills growth rate similar to normal-hearing peers

  • Risks

– Total blood volume: 80mL per kg – Facial nerve position – Underdeveloped mastoid tip – Device migration/profile

22

slide-12
SLIDE 12

12

Will Older Children Catch Up?

23

Niparko, et al., 2010

Severity of SNHL

24

slide-13
SLIDE 13

13

Patients with Residual Hearing

  • More likely to be good performers

– Children with pure tone thresholds 70 dB and good HA benefit (Mondain, et l., 2002) – Improved speech perception post-CI – Pre-implant 21%, post-implant 84%

  • Preservation of residual hearing

– Minimal trauma cochleostomy and insertion – As high as 60% retain residual hearing (Skarzynski, et al., 2002)

  • Bilateral CI: Standard + Hybrid (Gantz, et al., 2010)

– Equivalent performance 10- and 24-electrode arrays

  • Caveat: children at higher risk for progressive

loss

25 26

Auditory Neuropathy

  • Present OAEs/cochlear microphonic with SNHL or

abnormal ABR

  • No progress with auditory or language skills

– -- refer for CI evaluation – CI may offer neural synchronization

  • Outcomes are variable

– Comparable to SNHL in those without other medical/cognitive issues – Counseling is key

slide-14
SLIDE 14

14

Developmental Delay

  • Cognitive and developmental delay

– may slow rate of rehabiliation post-CI – May require multiple modes of communication – Still improve QOL, communication, self-sufficiency and socialization

  • Counseling is key

27 28

Bilateral Implants

  • The potential benefits of bilateral implants

– Insures that the best ear is implanted – May allow some of the benefits of binaural hearing – May avoid the effects of auditory deprivation on the unimplanted ear – Signifiantly more audition and vocalization 1 year post-implantation (Tait, et al., 2010) – Improved early complex expressive and receptive language (Wie, 2010)

slide-15
SLIDE 15

15

Adolescents with Long-term Hearing Loss

  • Highly variable outcome
  • Congenital Deafness:

– Some able to convert to oral communication – Improvements in open set recognition – 1/3 good performers – Factors: length of deafness, length of device use, mode of communication, degree of hearing loss, cause of hearing loss, use of speech therapy

Kos, et. Al., 2009; Heman-Ackah, et al., 2012

29

Adolescents

  • Progressive Hearing Loss

– Some of our best performers – Resistant to proceeding with implantation

  • “larger HA”
  • Stigma
  • Used to compensation

30

slide-16
SLIDE 16

16

Progressive HL

  • Children with progressive hearing loss should

be followed closely for reassessment of CI candidacy

31

Unilateral loss

  • Asymmetric hearing loss

– Unilateral aidable hearing loss/contralateral deaf ear – Risk of progression?

  • Unilateral SNHL

– Similar benefits to unilateral aiding (Hassepass, et al., 2013)

32

slide-17
SLIDE 17

17

Success

33 34

Summary

  • Selective additional testing based on

history/clinical findings

  • Ophthalmologic and ECG in all severe-to

profound negative on GJB2 and CT imaging

  • Genetic counseling for all patients undergoing

genetic testing

  • Children may have complex issues that need to

be fully evaluated in the CI work-up

  • Early referral of children for CI is best
  • Counseling families on expectations and

commitment is the key to success

slide-18
SLIDE 18

18

35

Thank you!

slide-19
SLIDE 19

19

References

  • available upon request

37